1-2 of 2
Antonella Iuliano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6722: OFD1 as a novel biomarker in cholangiocarcinoma: insights into ciliary dysfunction and tumor growth

Fabiola Piscopo, Anna Barbato, Massimiliano Salati, Carla Pollastro, Giorgia Gitano, Alberto Marino, Lorenzo Evangelista, Luigi Ferrante, Antonella Iuliano, Luca Reggiani-Bonetti, Maria Salatiello, Pasquale Pisapia, Umberto Malapelle, Giancarlo Troncone, Massimo Dominici, Brunella Franco, Pietro Carotenuto
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6722.
https://doi.org/10.1158/1538-7445.AM2025-6722
Published: 21 April 2025
View articletitled, Abstract 6722: OFD1 as a novel biomarker in cholangiocarcinoma: insights into ciliary dysfunction and tumor growth
Journal Articles

Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma

Carla Mottini, Hideo Tomihara, Diego Carrella, Alessia Lamolinara, Manuela Iezzi, Justin K. Huang, Carla A. Amoreo, Simonetta Buglioni, Isabella Manni, Frederick S. Robinson, Rosalba Minelli, Ya'an Kang, Jason B. Fleming, Michael P. Kim, Christopher A. Bristow, Daniela Trisciuoglio, Antonella Iuliano, Donatella Del Bufalo, Diego Di Bernardo, Davide Melisi, Giulio F. Draetta, Gennaro Ciliberto, Alessandro Carugo, Luca Cardone
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5612–5625.
https://doi.org/10.1158/0008-5472.CAN-19-0187
Published: 01 November 2019
View articletitled, Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
Open the PDF for Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data